Navigation Links
Treatment Option Shortens Path to Pregnancy
Date:6/19/2009

Skipping one phase when treating infertility also cuts costs, study finds

FRIDAY, June 19 (HealthDay News) -- Among couples going to fertility clinics, pregnancy occurred more quickly -- and for less money -- when they took an accelerated route to in vitro fertilization, a new study has found.

The advantages came when the researchers eliminated one step in the fertility treatment -- the gonadotropin-stimulated intrauterine insemination cycle. Gonadotropin is a follicle-stimulating hormone.

Working with couples at Boston IVF and Harvard Vanguard Medical Associates, the researchers divided 503 couples into two groups. Women in one group underwent conventional treatment -- three cycles of intrauterine insemination (IUI) using clomiphene citrate to stimulate ovulation, followed by three gonadotropin-stimulated IUI cycles, then up to six cycles of in vitro fertilization (IVF).

IUI is a procedure in which a thin, flexible catheter is threaded through the cervix and used to inject washed sperm directly into the uterus. In IVF, egg and sperm are joined outside the uterus in a petri dish, and the fertilized egg is then placed into the uterus.

Women in the other group went straight from the three clomiphene citrate-stimulated IUI cycles to the IVF cycles.

For women who skipped the gonadotropin-stimulated IUI cycle (also called FSH-stimulated cycle), the average time to pregnancy was eight months, compared with 11 months for those on the lengthier, conventional fertility-treatment program.

The study also found that the average delivery charges, based on insurance data, were $9,800 lower for those in the accelerated group and that couples saved, on average, $2,624, the study reported.

Women in the accelerated group were less likely to have multiple births, which helped lower the cost, according to the study.

Overall, 64 percent of the women, who ranged in age from 21 to 39, had a baby. That included 171 of 256 in the accelerated program and 150 of 247 in the lengthier program.

The study appears online June 16 in Fertility and Sterility.

"This is a very important study that will likely influence physicians to reduce the number of stimulated inseminations for patients with unexplained infertility," Elizabeth Ginsburg, president of the Society for Assisted Reproductive Technology, said in a news release from the group. "Adoption of such an accelerated course of treatment could result in many patients conceiving in less time with less expense."

More information

The American Pregnancy Association has more on in vitro fertilization.



-- Jennifer Thomas



SOURCE: American Society for Reproductive Medicine, news release, June 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization
2. Asthma Discovery May Lead to Better Treatments
3. Dysport Available! New Wrinkle Treatment in Washington, DC Offers Botox Alternative
4. Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm
5. VIDEO: Cancer Treatment Centers of America Selects Site in GA for Proposed Hospital Serving Patients in Southeast
6. St. Charles Surgical Hospital Announces Dedicated Lymphedema Treatment Program
7. 4th ESU master class on medical treatment for urological cancer held in Barcelona, Spain
8. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
9. Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States
10. Lifelike Robot Provides Innovative Rehabilitation Treatment for Patients
11. Researchers compare different systems of measuring treatment intensity in hypertension care
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treatment Option Shortens Path to Pregnancy
(Date:5/25/2016)... ... ... The Bank of America Charitable Foundation has awarded a grant to the General ... employment and successful careers in healthcare. On Wednesday, May 4th, Rick Bridwell, Bank of ... Medisend, parent organization and home of the General Myers Veterans Program. , “The ...
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot ... by CIOReview. , In a deliberate session with the honorary industrial experts, a list ... concluded with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit ... unique integrative medical wellness offerings of Europe, a continent that pioneered the medical/wellness concept ... hear from numerous pioneers in medical wellness, including Henri Chenot, Founder of the Chenot ...
(Date:5/25/2016)... FRANCISCO, CA (PRWEB) , ... May 25, 2016 , ... ... School of Nursing and Health Professions. She will lead a team of more than ... Team. Baker will begin her role as dean in late August. , Baker comes ...
(Date:5/25/2016)... ... May 25, 2016 , ... BeniComp Insurance Company, a ... in their clients' employee participation for their wellness initiatives. BeniComp clients experience ... high-deductible health plan with outcome-based deductible incentives. As a result, BeniComp clients have ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Deutschland und GERMANTOWN, Maryland ... Zusammenarbeit mit Therawis bedient dringenden ... Brustkrebs   QIAGEN N.V. (NASDAQ: ... heute bekannt, eine Lizenz- und Entwicklungsvereinbarung mit Therawis ... für die Onkologie eingegangen zu sein. Ein erstes ...
(Date:5/25/2016)... 25, 2016 According to market ... Growth and Demand Forecast to 2022 - Industry Insights ... Others)" published by P&S Market Research, the global insulin ... 2015, and it is expected to grow at a ... insulin pump segment is expected to witness the fastest ...
(Date:5/25/2016)... MedDay, a biotechnology company focused on ... presentation entitled "High doses of biotin in progressive multiple sclerosis: ... by Professor Ayman Tourbah , Principal Investigator of the ... Academy of Neurology (EAN) in Copenhagen, Denmark ... take place on Sunday, 29 May 2016 from 14:45 to ...
Breaking Medicine Technology: